GALVmed 2030 Strategy is a roadmap for the coming years in our commitment to improving livestock health and the livelihoods of small-scale producers.
GALVmed harnesses the best available expertise and capabilities to develop vaccines, medicines and diagnostics for the major livestock diseases impacting smallholders.
Board Directors serve for a maximum six year term and bring to GALVmed a wide range of expertise and knowledge from a wide range of organisations in: industry, public sector and non-governmental.
We depend on our relationships our partners to ensure that livestock vaccines and health products are sustainably available and accessible to livestock farmers.
GALVmed is a diverse organisation, spread out among three continents, consisting of professionals from 15 nationalities.
To make a real difference by facilitating provision of animal health tools within a sustainable economic framework.